TetraLogic Pharmaceuticals Corporation
TLOG
$0.00
$0.000.00%
OTC PK
| 09/30/2016 | 06/30/2016 | 03/31/2016 | 12/31/2015 | 09/30/2015 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 9.38M | 10.43M | 10.93M | 11.10M | 11.33M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 21.29M | 28.48M | 35.19M | 38.50M | 37.92M |
| Operating Income | -21.29M | -28.48M | -35.19M | -38.50M | -37.92M |
| Income Before Tax | -43.04M | -42.98M | -48.11M | -49.72M | -47.39M |
| Income Tax Expenses | -2.32M | -- | -- | -- | -- |
| Earnings from Continuing Operations | -40.72 | -42.98 | -48.11 | -49.72 | -47.39 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -40.72M | -42.98M | -48.11M | -49.72M | -47.39M |
| EBIT | -21.29M | -28.48M | -35.19M | -38.50M | -37.92M |
| EBITDA | -21.14M | -28.29M | -34.97M | -38.31M | -37.74M |
| EPS Basic | -1.64 | -1.75 | -1.99 | -2.10 | -2.06 |
| Normalized Basic EPS | -0.70 | -0.87 | -1.02 | -1.12 | -1.16 |
| EPS Diluted | -1.65 | -1.76 | -2.00 | -2.10 | -2.06 |
| Normalized Diluted EPS | -0.70 | -0.87 | -1.02 | -1.12 | -1.16 |
| Average Basic Shares Outstanding | 99.09M | 98.15M | 96.71M | 94.76M | 92.30M |
| Average Diluted Shares Outstanding | 99.09M | 98.18M | 96.79M | 94.87M | 92.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |